Journal
NEUROSURGERY
Volume 74, Issue 4, Pages E447-E455Publisher
OXFORD UNIV PRESS INC
DOI: 10.1227/NEU.0000000000000251
Keywords
Adenoma; Capecitabine; Neuroendocrine cancer; Pituitary; Temozolomide
Categories
Funding
- National Institutes of Health [NCI-RC2-148346, NCI-ROI 98712]
- Chemotherapy Foundation
- Sackler Foundation
- Phi Beta Psi Sorority grant
- Sol Berg Foundation
- Merck
Ask authors/readers for more resources
BACKGROUND AND IMPORTANCE: Rarely, corticotrophic pituitary tumors take on an aggressive form characterized by rapid growth, invasion into local structures, compression of cranial nerves, and possible spread to distant sites. When conventional surgery, radiation therapy, and hormones fail to control progression and symptoms, alternative therapies are needed. A novel chemotherapeutic regimen of capecitabine and temozolomide (CAPTEM), originally designed in our laboratory, demonstrated dramatic antineoplastic effects against corticotrophic pituitary tumors. CLINICAL PRESENTATION: We present a case series of 4 patients with aggressive, adrenocorticotrophic hormone-producing pituitary tumors who had previously depleted all surgical, radiation, and hormonal therapies and were then treated with CAPTEM. Dramatic clinical improvements in neurological deficits and Cushing symptoms were evident in all patients after treatment was initiated. Confirmed by radiographic imaging, 2 of 4 patients demonstrated complete regression of disease, 1 patient had a 75% regression, and the fourth patient has ongoing stable disease for >4.5 years at the time of this writing. Immunohistochemical analysis of patients' tumor samples showed low O-6-methyguanyl methyltransferase expression and adequate levels of mismatch repair enzymes (MLH-1, MSH-2, MSH-6, and PMS-2), which are important for the in vivo efficacy of CAPTEM. CONCLUSION: This is the first report of prolonged antitumor response to and radiographic complete remissions as a result of CAPTEM in patients with aggressive pituitary tumors who had exhausted all other therapies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available